Choate Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-561
| Closed | -$356K | – | 485 |
|
|
2025
Q1 | $356K | Buy |
561
+10
| +2% | +$6.34K | 0.01% | 304 |
|
|
2024
Q4 | $392K | Buy |
551
+37
| +7% | +$26.4K | 0.01% | 295 |
|
|
2024
Q3 | $540K | Buy |
514
+21
| +4% | +$22.1K | 0.01% | 259 |
|
|
2024
Q2 | $518K | Sell |
493
-2
| -0.4% | -$2.1K | 0.01% | 246 |
|
|
2024
Q1 | $476K | Sell |
495
-60
| -11% | -$57.7K | 0.01% | 272 |
|
|
2023
Q4 | $487K | Sell |
555
-76
| -12% | -$66.8K | 0.02% | 247 |
|
|
2023
Q3 | $519K | Buy |
631
+109
| +21% | +$89.7K | 0.02% | 235 |
|
|
2023
Q2 | $375K | Buy |
522
+128
| +32% | +$92K | 0.02% | 224 |
|
|
2023
Q1 | $324K | Hold |
394
| – | – | 0.02% | 221 |
|
|
2022
Q4 | $284K | Hold |
394
| – | – | 0.02% | 227 |
|
|
2022
Q3 | $271K | Hold |
394
| – | – | 0.02% | 210 |
|
|
2022
Q2 | $233K | Hold |
394
| – | – | 0.01% | 237 |
|
|
2022
Q1 | $275K | Hold |
394
| – | – | 0.01% | 255 |
|
|
2021
Q4 | $249K | Hold |
394
| – | – | 0.01% | 254 |
|
|
2021
Q3 | $238K | Hold |
394
| – | – | 0.02% | 243 |
|
|
2021
Q2 | $220K | Buy |
+394
| New | +$220K | 0.01% | 253 |
|
|
2013
Q4 | – | Sell |
-729
| Closed | -$228K | – | 267 |
|
|
2013
Q3 | $228K | Buy |
+729
| New | +$228K | 0.02% | 238 |
|